asl 7022 has been researched along with dobutamine in 4 studies
| Studies (asl 7022) | Trials (asl 7022) | Recent Studies (post-2010) (asl 7022) | Studies (dobutamine) | Trials (dobutamine) | Recent Studies (post-2010) (dobutamine) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 6,357 | 818 | 1,011 |
| Protein | Taxonomy | asl 7022 (IC50) | dobutamine (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 1 | Homo sapiens (human) | 4.17 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 5.551 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 5.519 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 3.975 | |
| Beta-2 adrenergic receptor | Homo sapiens (human) | 1.517 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 0.383 | |
| Beta-1 adrenergic receptor | Homo sapiens (human) | 1.944 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 0.599 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 2.966 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.383 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.114 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 1.895 | |
| D(3) dopamine receptor | Homo sapiens (human) | 4.985 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.155 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 2.518 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, WG; Gorczynski, RJ; Stout, DM | 1 |
| Horng, JS; Messick, K; Ruffolo, RR | 1 |
| Ruffolo, RR; Yaden, EL | 1 |
| Morgan, EL; Ruffolo, RR | 1 |
4 other study(ies) available for asl 7022 and dobutamine
| Article | Year |
|---|---|
N-Aralkyl substitution of 2-amino-5,6- and -6,7-dihydroxy-1,2,3,4-tetrahydronaphthalenes. 1. Cardiac and pressor/depressor activities.
Topics: Animals; Blood Pressure; Desipramine; Dogs; Guinea Pigs; Heart; In Vitro Techniques; Myocardial Contraction; Naphthalenes; Tetrahydronaphthalenes | 1981 |
Interactions of three inotropic agents, ASL-7022, dobutamine and dopamine, with alpha- and beta-adrenoceptors in vitro.
Topics: Animals; Aorta; Catecholamines; Cerebellum; Cerebral Cortex; Dobutamine; Dopamine; Female; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Contraction; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Uterine Contraction | 1984 |
Selective alpha 2-adrenoceptor agonist activity of the novel inotropic agent, ASL-7022: comparison with dobutamine.
Topics: Adrenergic beta-Agonists; Animals; Blood Pressure; Cardiotonic Agents; Catecholamines; Dobutamine; Male; Rats; Rats, Inbred Strains; Yohimbine | 1983 |
Interaction of the novel inotropic agent, ASL-7022, with alpha and beta adrenoceptors in the cardiovascular system of the pithed rat: comparison with dobutamine and dopamine.
Topics: Animals; Blood Pressure; Cardiotonic Agents; Cardiovascular System; Catecholamines; Decerebrate State; Dobutamine; Dopamine; Heart Rate; Male; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta | 1984 |